Biomarker for chronic inflammatory lung diseases
OwnerNelly Frossard, Jacques Haiech +5inventors
InventorsNelly Frossard, Jacques Haiech, Christine Lehalle, Romain Kessler, Antoine Magnan, Pascal Chanez, Jean-Luc Galzi
Life of this patent
Estimating the term…
Abstract
The invention relates to an in vitro method for the diagnosis and/or prognosis and/or evaluation of the progression of a chronic inflammatory lung disease in a subject, using the level of expression of the GPR15 G protein-coupled receptor gene as a biomarker for the disease.
Claims12
1-15. (canceled)
An in vitro method of diagnosis which makes it possible to determine whether a patient is suffering from asthma or from chronic obstructive pulmonary disease (COPD), in which the G protein-coupled receptor 15 (GPR15) gene expression level is measured in a biological sample from the patient, an underexpression of GPR15 being indicative of asthma and an overexpression of GPR15 being indicative of COPD.
Dependencies are inferred from the claim text.